scispace - formally typeset
Search or ask a question

Showing papers by "Cabot Corporation published in 2020"



Journal ArticleDOI
TL;DR: In their Commentary Saber et al. argue that chronic inhalation studies in rats can be used for assessing the lung cancer risk of insoluble nanomaterials and make several significant errors in their interpretation and representation of the underlying science.
Abstract: In their Commentary Saber et al. (Part Fibre Toxicol 16: 44, 2019) argue that chronic inhalation studies in rats can be used for assessing the lung cancer risk of insoluble nanomaterials. The authors make several significant errors in their interpretation and representation of the underlying science. In this Letter to the Editor we discuss these inaccuracies to correct the scientific record. When the science is recounted accurately it does not support Saber et al’s statements and conclusions.

Proceedings ArticleDOI
Limeng Chen1
01 Jul 2020
TL;DR: In this article, a novel carbon additive, carbon nanostructure (CNS), is introduced as an effective additive for EMI shielding plastic and silicone compounds, which can also enable better performance/processing balance of compounds compared to traditional metal-based EMI-based additive.
Abstract: A novel carbon additive, carbon nanostructure (CNS), is introduced as an effective additive for EMI shielding plastic and silicone compounds. Compounds containing CNS have higher EMI shielding efficiency than compounds containing other carbon-based additives. CNS can also enable better performance/processing balance of compounds compared to traditional metal-based EMI shielding additives.

Patent
03 Dec 2020
TL;DR: In this article, a set of compositions (e.g., pigment dispersions or ink compositions such as inkjet ink compositions) comprising at least quinacridone magenta pigment and at least one synergist selected from compounds (A) and (B) having the following structures, wherein each n is an integer independently ranging from 1 to 4, and R1-R3 are each independently selected from H, CH3, Cl, and F, and A) (B).
Abstract: Disclosed herein are compositions (e.g., pigment dispersions or ink compositions such as inkjet ink compositions) comprising at least one quinacridone magenta pigment and at least one synergist selected from compounds (A) and (B) having the following structures, wherein each n is an integer independently ranging from 1 to 4, and R1-R3 are each independently selected from H, CH3, Cl, and F, and (A) (B).